TRIM65 promotes the accumulation of products related to uracil metabolism and palmitic acid via NF2/YAP1 signaling, orchestrating metabolic and immune advantages to drive the progression of HCC. The gene discussed is NF2; the disease is hepatocellular carcinoma.